Regulatory & Safety

(Image: Getty/koksikoks)

Novartis recalls NDEA-contaminated tablets in US

By Flora Southey

Sandoz is the latest Zhejiang Huahai Pharmaceutical customer to issue a nationwide recall after trace amounts of a probable carcinogen were found in the supplier’s API.